GÖTTINGEN, Germany,
July 5, 2021 /PRNewswire/
-- Sartorius announces today that it expects strong first–half
performance and raises its forecast for the full year of 2021. For
the first six months ended June 30,
the company expects revenue growth to be approximately 60% in
constant currencies with an underlying EBITDA margin1
slightly above 34.0%. Revenue of the Bioprocess Solutions Division
is anticipated to grow by around 63% with an underlying EBITDA
margin1 of 36.0 to 36.5%, and growth of the Lab
Products & Services Division is estimated to be approximately
52% with an underlying EBITDA margin1 at 26.0 to 26.5%.
This better-than-expected performance is broad-based across both
divisions and all geographies and is backed by continuously strong
order intake, stable supply chains, and expanded production
capacities.
Based on the dynamic business development so far and on
increasingly robust prospects for the second half, Sartorius is
raising its forecast for the full year: The company now
projects consolidated sales growth of around 45% (previously 35%)
and an underlying EBITDA margin1 of about 34%
(previously about 32%) for the Group. For the Bioprocess Solutions
Division, sales are anticipated to increase by about 50%
(previously 40%), and the division's underlying EBITDA
margin1 is projected at about 36% (previously at about
34%). Sales growth for the Lab Products & Services Division is
now expected to be 30% (previously 20%) at an underlying EBITDA
margin1 of about 26% (previously about 24%). All
figures are given in constant currencies as in the past.
Due to the pandemic, this guidance continues to be subject to
higher uncertainty than usual and is particularly based on the
assumptions that supply chains will remain stable and production
lines will stay up and running. The mid-term targets up to 2025
that were updated in January 2021 are
unaffected by these adjustments.
Sartorius will publish the full set of half-year figures for
2021 as scheduled on July 21, 2021,
and will hold a conference call on the same day.
1 Sartorius publishes alternative performance measures that are
not defined by international accounting standards. These are
determined with the aim of improving the comparability of business
performance over time and within the industry.
- Relevant / underlying EBITDA: earnings before interest, taxes,
depreciation and amortization and adjusted for extraordinary
items
This notification according to Article 17 MAR contains
statements about the future development of the Sartorius Group. The
content of these statements cannot be guaranteed as they are based
on assumptions and estimates that harbor certain risks and
uncertainties. This is a translation of the original
German-language announcement. The Sartorius Group shall not assume
any liability for the correctness of this translation. The original
German ad hoc announcement is the legally binding version.
Furthermore, the Sartorius Group reserves the right not to be
responsible for the topicality, correctness, completeness or
quality of the information provided. Liability claims regarding
damage caused by the use of any information provided, including any
kind of information which is incomplete or incorrect, will
therefore be rejected.
Contact
Petra Kirchhoff
Head of Corporate Communications and Investor Relations
+49 (0)551.308.1686
petra.kirchhoff@sartorius.com
https://www.sartorius.com/en
Logo -
https://mma.prnewswire.com/media/1472792/Sartorius_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/sartorius-provides-preliminary-first-half-financial-key-figures-and-raises-forecast-for-2021-301325600.html
SOURCE Sartorius AG